Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgens”

1,153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,153 results

Not applicableUnknownNCT04065100
What this trial is testing

Sebum Measurement in Newborn to Detect Hyperexposure to Androgens

Who this might be right for
Polycystic Ovary Syndrome
Homerton University Hospital NHS Foundation Trust 200
Testing effectiveness (Phase 2)UnknownNCT00497458
What this trial is testing

Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects

Who this might be right for
Breast CancerArthralgiaOsteoporosis
Havah Therapeutics Pty Ltd 90
Large-scale testing (Phase 3)Study completedNCT01020448
What this trial is testing

Effect of Triptorelin (Decapeptyl®) 22.5 mg on Two Biomarkers in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Ipsen 339
Testing effectiveness (Phase 2)Study completedNCT00175617
What this trial is testing

Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss

Who this might be right for
Female Pattern Hair Loss
University of British Columbia 40
Testing effectiveness (Phase 2)Ended earlyNCT01200810
What this trial is testing

Bicalutamide and RO4929097 in Treating Patients With Previously Treated Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 10
Not applicableUnknownNCT03489668
What this trial is testing

Androgen Responses to hCG and Ovarian Morphology in PCOS

Who this might be right for
PCOS
Poznan University of Medical Sciences 100
Not applicableStudy completedNCT01078545
What this trial is testing

Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

Who this might be right for
Advanced Prostate CancerLower Urinary Tract Symptoms
Abbott 729
Testing effectiveness (Phase 2)Active Not RecruitingNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Testing effectiveness (Phase 2)Study completedNCT02789878
What this trial is testing

Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Instituto do Cancer do Estado de São Paulo 64
Testing effectiveness (Phase 2)Ended earlyNCT05551117
What this trial is testing

Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

Who this might be right for
Castration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more
MacroGenics 192
Early research (Phase 1)Study completedNCT00400335
What this trial is testing

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

Who this might be right for
HypogonadismHypogonadism, Male
GlaxoSmithKline 60
Not applicableStudy completedNCT06167824
What this trial is testing

Assessment of Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure Without Androgen Deprivation Therapy

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 302
Large-scale testing (Phase 3)UnknownNCT00796458
What this trial is testing

Androgen Ablation With or Without Docetaxel in Treating Patients With Advanced Prostate Cancer

Who this might be right for
PainProstate Cancer
A.O.U. San Giovanni Battista di Torino, Italy 200
Testing effectiveness (Phase 2)Study completedNCT00919035
What this trial is testing

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 21
Not applicableStudy completedNCT04057859
What this trial is testing

PCa Patients Managed With ADT to Examine the Effect of Nutritional Guidance and Aerobic/Resistance Fitness Training

Who this might be right for
Cancer of the Prostate
CMX Research 271
Not applicableLooking for participantsNCT04944940
What this trial is testing

Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)

Who this might be right for
Spinal and Bulbar Muscular AtrophyKennedys DiseaseMotor Neuron Disease
National Institute of Neurological Disorders and Stroke (NINDS) 70
Early research (Phase 1)Study completedNCT02472275
What this trial is testing

PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer

Who this might be right for
Stage I Prostate AdenocarcinomaStage II Prostate AdenocarcinomaStage III Prostate Adenocarcinoma
Barbara Ann Karmanos Cancer Institute 8
Large-scale testing (Phase 3)Study completedNCT03016312
What this trial is testing

Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Who this might be right for
Prostatic Neoplasms, Castration-Resistant
Hoffmann-La Roche 759
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Not applicableNot Yet RecruitingNCT06430411
What this trial is testing

Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET Study

Who this might be right for
Prostate Cancer MetastaticProstate Cancer Metastatic to BoneProstate Cancer+3 more
Medical University of Vienna 500
Load More Results